Sophia Randolph, Chief Medical Officer at ALX ONCOLOGY HOLDINGS INC (ALXO), sold 14,704 shares at $64.20 ($950K) on 2021-08-10, disclosed to the SEC on 2021-08-11.
Open-market sale of $950k ALXO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.20 | 1,718 | $110K | 11.6% |
| 2 | $64.20 | 1,718 | $110K | 11.6% |
| 3 | $64.76 | 5,599 | $363K | 38.2% |
| 4 | $64.76 | 5,599 | $363K | 38.2% |
| 5 | $65.46 | 70 | $5K | 0.5% |
| Total | $64.63 avg | 14,704 |
| $950K |
| 100% |
| Filing → |
| ALXO | SELL | 2024-05-15 | $353K | — | Filing → |
| ALXO | SELL | 2024-01-03 | $47K | — | Filing → |
| ALXO | SELL | 2023-07-05 | $12K | — | Filing → |